Safety profile of lamotrigine in overdose

Alibi, A.; Todd, A.; Husband, A.; Reilly, J.

Abstract

Background: Lamotrigine is an anticonvulsant as well as a mood stabilizer. Apart from its established use in the treatment of epilepsy, there has been an expansion of its use in the treatment of mental disorders. Patients with epilepsy as well as those with mental disorders are at increased risk of deliberate drug overdoses. An evidence base for the safety profile of lamotrigine in overdose is an essential tool for prescribers. The objective of this study was to carry out a narrative synthesis of the existing evidence for the safety profile of lamotrigine in overdose. Methods: A systematic search was conducted of EMBASE (1974 to December 2015), MEDLINE (1946 to December 2015), PsycINFO (1806 to December 2015) and CINAHL (1981 to December 2015) databases. Studies were included in which there was a deliberate or accidental single drug overdose of lamotrigine, with its toxic effects described. Studies that did not involve an overdose were excluded. A narrative synthesis of the described toxic effects was carried out. Results: Out of 562 articles identified, 26 studies were included, mainly in the form of case reports and series. The most commonly described toxic effects of lamotrigine were on the central nervous system, specifically seizures, movement disorders and reduced consciousness. Other toxic effects included QTc interval and QRS complex prolongations, hypersensitivity reactions, serotonin syndrome as well as rhabdomyolysis possibly due to seizures and/or agitation. Deaths were recorded in two studies, with cardiovascular and neurological toxic effects described. Conclusions: Even though lamotrigine has been reported to be well tolerated, there is a risk of toxic effects which can be life threatening in overdose. This needs to be borne in mind when prescribing to patients at an increased risk of deliberate drug overdose.

Citation

Alibi, A., Todd, A., Husband, A., & Reilly, J. (2016). Safety profile of lamotrigine in overdose. Therapeutic Advances in Psychopharmacology, 6(6), 369-381. https://doi.org/10.1177/2045125316656707

• Journal Article Type: Article
• Online Publication Date: Aug 8, 2016
• Publication Date: Dec 1, 2016
• Deposit Date: Aug 23, 2016
• Publicly Available Date: Aug 24, 2016
• Journal: Therapeutic Advances in Psychopharmacology
• Print ISSN: 2045-1253
• Electronic ISSN: 2045-1261
• Publisher: SAGE Publications
• Peer Reviewed: Peer Reviewed
• Volume: 6
• Issue: 6
• Pages: 369-381
• DOI: https://doi.org/10.1177/2045125316656707